STRYKER CORP SYK

Latest FY: 2025 Healthcare Medical Devices
Market Price $338.83
Market Cap $130.77B
P/E Ratio 40.34
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑11.2% YoY
$25.12B
3-Yr CAGR: 10.8%
Net Income ↑8.5% YoY
$3.25B
Net Margin: 12.9%
Free Cash Flow ↑22.8% YoY
$4.28B
FCF Yield: 3.28%
EPS (Diluted) ↑8.2% YoY
$8.40
Basic: $8.49
Return on Equity Efficiency
14.5%
ROA: 6.8%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (SYK)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $11,325.0M $7,495.0M $1,647.0M $4.35 $1,812.0M $1,322.0M
FY 2017 $12,444.0M +9.9% $8,173.0M $1,020.0M -38.1% $2.68 -38.4% $1,559.0M $961.0M -27.3%
FY 2018 $13,601.0M +9.3% $8,938.0M $3,553.0M +248.3% $9.34 +248.5% $2,610.0M $2,038.0M +112.1%
FY 2019 $14,884.0M +9.4% $9,696.0M $2,083.0M -41.4% $5.48 -41.3% $2,191.0M $1,542.0M -24.3%
FY 2020 $14,351.0M -3.6% $9,057.0M $1,599.0M -23.2% $4.20 -23.4% $3,277.0M $2,790.0M +80.9%
FY 2021 $17,108.0M +19.2% $10,968.0M $1,994.0M +24.7% $5.21 +24.0% $3,263.0M $2,738.0M -1.9%
FY 2022 $18,449.0M +7.8% $11,578.0M $2,358.0M +18.3% $6.17 +18.4% $2,624.0M $2,036.0M -25.6%
FY 2023 $20,498.0M +11.1% $13,058.0M $3,165.0M +34.2% $8.25 +33.7% $3,711.0M $3,136.0M +54.0%
FY 2024 $22,595.0M +10.2% $14,440.0M $2,993.0M -5.4% $7.76 -5.9% $4,242.0M $3,487.0M +11.2%
FY 2025 $25,116.0M +11.2% $16,065.0M $3,246.0M +8.5% $8.40 +8.2% $5,044.0M $4,283.0M +22.8%
$

Valuation

Market Price $338.83
Market Cap $130.77B
Enterprise Value $141.62B
P/E Ratio 40.34
P/B Ratio 5.79
FCF Yield 3.28%
Dividend Yield 2.51%
Shares Outstanding 383,400,000
%

Profitability & Margins

Gross Margin 63.96%
Operating Margin 19.47%
Net Margin 12.92%
Return on Equity (ROE) 14.48%
Return on Assets (ROA) 6.78%
Asset Turnover 0.52x
Revenue 3-Yr CAGR 10.83%
🛡️

Financial Health & Liquidity

Current Ratio 1.89
Cash Ratio 0.51
Debt / Equity 0.663
Debt / Assets 0.311
Cash & Equivalents $4.01B
Total Debt $14.86B
Book Value / Share $58.48
💧

Cash Flow Efficiency

Operating Cash Flow $5.04B
Capital Expenditures (CapEx) $761.00M
Free Cash Flow $4.28B
OCF / Revenue 20.08%
FCF / Revenue 17.05%
FCF 3-Yr CAGR 28.13%
🏷️

Per Share Metrics

EPS (Diluted) $8.40
EPS (Basic) $8.49
Dividends / Share $8.49
Book Value / Share $58.48
EPS YoY Growth 8.25%
🏛️

Balance Sheet (FY 2025)

Total Assets $47.84B
Total Liabilities $25.42B
Stockholders' Equity $22.42B
Current Assets $14.76B
Current Liabilities $7.79B